Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease
US8784860B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Oct 27, 2005 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Jan 12, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/42
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.